Replies to post #31675 on Amarin Corp Plc (AMRN)

[HDGabor]

a.) I said "Yes, but no."
b.) I did not interpreted anything, House and Senate has different wording (directs /encourages) FDA Law Blog
c.) Not guaranted that the new guideline will be different. They could "revise" and re-issue the same guideline (not exactly the same, but for public comment read this).
d.) I could not find any amount on FDALB or in a Bill or House's report, so please help me and post the relevant link